Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elie Rassy

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Nature Reviews. Clinical Oncology|May 1, 2020
Progress in refining the clinical management of cancer of unknown primary in the molecular eraElie Rassy, Nicholas Pavlidis
Expert Review of Anticancer Therapy|August 12, 2020
The diagnostic challenges of patients with carcinoma of unknown primaryElie Rassy, Nicholas Pavlidis
Cancer Epidemiology|June 30, 2019
The currently declining incidence of cancer of unknown primaryElie Rassy, Nicholas Pavlidis
British Journal of Cancer|February 12, 2020
Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Elie Rassy, Tarek Assi, Nicholas Pavlidis
European Journal of Clinical Investigation|May 10, 2021
Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primaryElie Rassy, Stergios Boussios, Nicholas Pavlidis
Breast (Edinburgh, Scotland)|November 5, 2022
Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancerElie Rassy, Layal Rached, Barbara Pistilli
Journal of Advanced Research|June 25, 2020
What can we learn from cancer of unknown primary in canine oncology?Aline Khazzaka, Elie Rassy, Nicholas Pavlidis
International Journal of Clinical Oncology|June 17, 2019
Familial cancer of unknown primaryElie Rassy, Joseph Kattan, Nicholas Pavlidis
Therapeutic Advances in Medical Oncology|March 28, 2020
Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinomaElie Rassy, Ronan Flippot, Laurence Albiges
Head & Neck|July 14, 2019
Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primaryElie Rassy, Piero Nicolai, Nicholas Pavlidis
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Nature Reviews. Clinical Oncology|May 1, 2020
Progress in refining the clinical management of cancer of unknown primary in the molecular eraElie Rassy, Nicholas Pavlidis
Expert Review of Anticancer Therapy|August 12, 2020
The diagnostic challenges of patients with carcinoma of unknown primaryElie Rassy, Nicholas Pavlidis
Cancer Epidemiology|June 30, 2019
The currently declining incidence of cancer of unknown primaryElie Rassy, Nicholas Pavlidis
British Journal of Cancer|February 12, 2020
Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Elie Rassy, Tarek Assi, Nicholas Pavlidis
European Journal of Clinical Investigation|May 10, 2021
Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primaryElie Rassy, Stergios Boussios, Nicholas Pavlidis
Breast (Edinburgh, Scotland)|November 5, 2022
Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancerElie Rassy, Layal Rached, Barbara Pistilli
Journal of Advanced Research|June 25, 2020
What can we learn from cancer of unknown primary in canine oncology?Aline Khazzaka, Elie Rassy, Nicholas Pavlidis
International Journal of Clinical Oncology|June 17, 2019
Familial cancer of unknown primaryElie Rassy, Joseph Kattan, Nicholas Pavlidis
Therapeutic Advances in Medical Oncology|March 28, 2020
Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinomaElie Rassy, Ronan Flippot, Laurence Albiges
Head & Neck|July 14, 2019
Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primaryElie Rassy, Piero Nicolai, Nicholas Pavlidis
Pageof 10